Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Arrowhead Pharmaceuticals, Inc.

TRADE

NASDAQ: ARWRHealthcare / Biotechnology / USA
13.49-0.38-2.74%Vol 2 063 9311Y Perf 244.13%
Oct 17th, 2018 16:00
BID13.32 ASK13.99
Open13.53 Previous Close13.87
Pre-Market14.05 After-Trading13.78
 0.18 1.30%  0.29 2.15%
Target Price
24.42 
Analyst Rating
Strong Buy 1.00
Potencial %
81.02 
Finscreener Ranking
★★★+     53.36
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★+     44.01
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★+     56.14
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 187 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
54.08 
Earnings Date
11th Dec 2018

Today's Price Range

13.3014.23

 

52wk Range

3.0122.39

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-28.40%
3 Months
-19.08%
6 Months
92.44%
1 Year
244.13%
3 Years
150.74%
5 Years
71.41%

Quotes

Name / TickerPriceChg.Chg.%
ARWR13.49-0.3800-2.74
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.50
Current Ratio 8.70
Long Term Debt to Total Capital 0.02
Total Debt to Equity 0.02
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-404.50
EBITDA Margin-370.50
Pre-tax Profit Margin-21 890.80
Profit Margin-78.74
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 11.28
PS Ratios 236.12
Price to Cash Flow -
Price to Free Cash Flow -25.50
Cash Flow Per Share -0.67
Price to Tangible Book13.88
Book Value per Share1.16
Enterprise Value (in ths.)1 095 880
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-67.77
ROE last 12 Months -55.97
Return on Assets (5Y Avg) -51.42
ROA last 12 Months -47.20
Return on Capital (5Y Avg) -55.80
ROC last 12 Months -55.15
Return on invested Capital Q -14.10
Return on invested Capital Y-37.73
Assets Turnover0.00
Receivables Turnover118.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)4 887
Revenue per Share 0.06
Revenue Growth 3 Years 230.44
Revenue Growth 5 Years 113.54
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.19-0.185.26
Q02 2018-0.18-0.180.00
Q01 2018-0.18-0.180.00
Q04 2017-0.12-0.14-16.67
Q03 2017-0.13-0.0746.15
Q02 2017-0.12-0.0833.33
Q01 2017-0.18-0.175.56
Q04 2016-0.33-0.316.06
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1525.00Positive
9/2018 FY-0.6513.33Positive
12/2018 QR-0.1611.11Positive
9/2019 FY-0.579.52Positive
Next Report Date11th Dec 2018
Estimated EPS Next Report-0.15
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume2 063 931
Shares Outstanding (in ths.)88 020
Trades Count8 579
Dollar Volume25 800 845
Avg. Volume2 081 177
Avg. Weekly Volume2 387 626
Avg. Monthly Volume3 236 491
Avg. Quarterly Volume2 592 865

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

81%19%

Bearish Bullish

48%52%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.33

There are no comments yet.

News

x